Basics Cogent Biosciences, Inc. IPO Date: March 26, 2018 Sector: Healthcare Industry: Biotech Market Cap: $1.53B Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 3.22% Avg Daily Range (30 D): $0.22 | 2.12% Avg Daily Range (90 D): $0.21 | 3.37% Institutional Daily Volume Avg Daily Volume: .59M Avg Daily Volume (30 D): 3.29M Avg Daily Volume (90 D): 2.06M Trade Size Avg Trade Size (Sh.): 109 Avg Trade Size (Sh.) (30 D): 116 Avg Trade Size (Sh.) (90 D): 113 Institutional Trades Total Inst.Trades: 1,662 Avg Inst. Trade: $1.61M Avg Inst. Trade (30 D): $1.75M Avg Inst. Trade (90 D): $1.57M Avg Inst. Trade Volume: .18M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.78M Avg Closing Trade (30 D): $3.67M Avg Closing Trade (90 D): $2.08M Avg Closing Volume: 190.86K     News Jul 9, 2025 @ 1:36 AM Cogent Biosciences Announces Pricing of Upsized Pu... Source: Christi Waarich Apr 15, 2025 @ 5:00 PM Gastrointestinal Stromal Tumor Market to Grow Rapi... Source: Delveinsight Jun 28, 2024 @ 1:18 PM Cogent (COGT) Up on SUMMIT Study Update Post Posit... Source: Zacks Equity Research Jun 14, 2024 @ 11:30 AM Cogent Biosciences Announces Additional Clinical D... Source: Cogent Biosciences, Inc. May 23, 2024 @ 9:05 PM Cogent Biosciences Appoints Cole Pinnow as Chief C... Source: Cogent Biosciences, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.78 $-.53 $-.52 Diluted EPS $-1.78 $-.53 $-.52 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -284.08M $ -73.53M $ -71.99M Operating Income / Loss $ -299.66M $ -75.58M $ -74.93M Cost of Revenue $ $ $ Net Cash Flow $ 39.38M $ 1.6M $ 27.84M PE Ratio     Splits Nov 09, 2020:   1:4